Esophageal squamous cell carcinoma (ESCC) accounts for 80% of all esophageal cancers
worldwide, and esophageal squamous dysplasia (ESD) is the only histopathology that …

Background The aim of this systematic review is to provide an overview of the diagnosis,
treatment options and treatment-related complications of cervical esophageal carcinoma …

The proliferating cell nuclear antigen (PCNA) has emerged as a promising candidate for the
development of novel cancer therapeutics. PCNA is a nononcogenic mediator of DNA …

BACKGROUND & AIMS: Barrett's esophagus (BE) is a highly premalignant disease that
predisposes to the development of esophageal adenocarcinoma (EAC); however, the …

Purpose Patients with localized esophageal carcinoma have a 5-year survival rate of less
than 20%. Patients are often treated similarly (ie, with preoperative chemoradiotherapy) but …

Esophageal squamous cell carcinoma (ESCC) is a major histological subtype of
esophageal cancer with inferior prognosis. Here, we conducted comprehensive …

Background Barrett's esophagus is an acquired metaplastic change that occurs in the distal
esophagus secondary to chronic gastroesophageal reflux. This premalignant condition …

To investigate the relationship between Barrett's esophagus (BE) and esophageal
adenocarcinoma (EAC), we determined gene expression profiles of discrete pathological …

Acute myeloid leukemia (AML) is a highly heterogeneous disease that remains untreatable.
MicroRNAs (miRNAs or miRs) play important roles in the pathogenesis of leukemia. miR‑21 …

Background: Fascin, an actin-binding protein, is usually expressed at a low level in normal
epithelium, but is markedly up regulated in several types of carcinomas. Reports on fascin …